ADSS2

adenylosuccinate synthase 2

Basic information

Region (hg38): 1:244408494-244451909

Previous symbols: [ "ADSS" ]

Links

ENSG00000035687NCBI:159OMIM:103060HGNC:292Uniprot:P30520AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADSS2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADSS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
19
clinvar
1
clinvar
20
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 19 1 0

Variants in ADSS2

This is a list of pathogenic ClinVar variants found in the ADSS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-244411376-G-A not specified Uncertain significance (Aug 22, 2023)2620908
1-244411378-G-T not specified Uncertain significance (Dec 13, 2022)3091332
1-244411414-T-G not specified Uncertain significance (Sep 23, 2023)3091330
1-244416022-A-C not specified Uncertain significance (Feb 27, 2024)3091328
1-244416040-G-A not specified Uncertain significance (Apr 07, 2023)2535060
1-244417653-C-T not specified Uncertain significance (Nov 29, 2023)3091325
1-244418795-C-T not specified Uncertain significance (Aug 21, 2023)2591808
1-244418852-T-C not specified Uncertain significance (Nov 07, 2023)3091367
1-244420253-T-A not specified Uncertain significance (Aug 28, 2023)2622004
1-244420280-A-C not specified Uncertain significance (Jun 27, 2022)3091356
1-244422841-T-G not specified Uncertain significance (Jun 10, 2024)3274101
1-244424348-T-C not specified Uncertain significance (Aug 09, 2021)3091350
1-244437677-G-A not specified Uncertain significance (Jul 05, 2023)2609845
1-244437682-A-T not specified Uncertain significance (Jul 05, 2023)2601214
1-244437718-A-C not specified Uncertain significance (Apr 08, 2022)3091344
1-244451659-G-T not specified Uncertain significance (Jul 25, 2023)2613498
1-244451673-G-C not specified Uncertain significance (Nov 29, 2021)3091338
1-244451769-C-T not specified Uncertain significance (Dec 15, 2022)3091354
1-244451772-C-A not specified Uncertain significance (Feb 23, 2023)2463247
1-244451799-A-C not specified Uncertain significance (Jul 13, 2022)3091343
1-244451805-C-T not specified Likely benign (Feb 10, 2022)3091336

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADSS2protein_codingprotein_codingENST00000366535 1343641
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3300.670125724071257310.0000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.221402360.5930.00001092950
Missense in Polyphen3498.4380.345391239
Synonymous0.6687784.80.9080.00000417869
Loss of Function3.65626.10.2300.00000127323

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008940.0000894
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.000.00
South Asian0.00006540.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in the de novo pathway and in the salvage pathway of purine nucleotide biosynthesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP.;
Pathway
Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Purine Nucleoside Phosphorylase Deficiency;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Xanthine Dehydrogenase Deficiency (Xanthinuria);Adenylosuccinate Lyase Deficiency;AICA-Ribosiduria;Thioguanine Action Pathway;Adenine phosphoribosyltransferase deficiency (APRT);Mitochondrial DNA depletion syndrome;Myoadenylate deaminase deficiency;Purine Metabolism;Molybdenum Cofactor Deficiency;Adenosine Deaminase Deficiency;Gout or Kelley-Seegmiller Syndrome;Lesch-Nyhan Syndrome (LNS);Xanthinuria type I;Xanthinuria type II;Nucleotide Metabolism;nfat and hypertrophy of the heart ;adenosine ribonucleotides <i>de novo</i> biosynthesis;Metabolism of nucleotides;Alanine Aspartate Asparagine metabolism;Metabolism;Nucleobase biosynthesis;Purine nucleotides nucleosides metabolism;superpathway of purine nucleotide salvage;Purine ribonucleoside monophosphate biosynthesis;purine nucleotides <i>de novo</i> biosynthesis (Consensus)

Recessive Scores

pRec
0.348

Intolerance Scores

loftool
0.365
rvis_EVS
0.01
rvis_percentile_EVS
54.95

Haploinsufficiency Scores

pHI
0.715
hipred
Y
hipred_score
0.708
ghis
0.591

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.955

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Adss
Phenotype

Zebrafish Information Network

Gene name
adssl
Affected structure
trunk
Phenotype tag
abnormal
Phenotype quality
necrotic

Gene ontology

Biological process
immune system process;AMP biosynthetic process;aspartate metabolic process;purine ribonucleoside monophosphate biosynthetic process;response to purine-containing compound;'de novo' AMP biosynthetic process;IMP metabolic process;response to ammonium ion;cellular response to electrical stimulus
Cellular component
cytoplasm;cytosol;plasma membrane;extracellular exosome
Molecular function
magnesium ion binding;adenylosuccinate synthase activity;protein binding;GTP binding;phosphate ion binding